drugset / Trial / NCT02425566

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

NCT02425566

Phase 1 Active not recruiting 12 enrolled Vanderbilt University
Non-randomizedSingle-groupOpen-labelOther

Summary

The purpose of this study is to better understand the role of the abdominal veins (splanchnic capacitance) and the sympathetic nervous system in human hypertension. The investigators will test the hypothesis that constriction of abdominal veins due to sympathetic activation contributes to human hypertension. Splanchnic capacitance will be assessed in normotensive and hypertensive subjects at baseline and during acute blockade of the autonomic nervous system.

Timeline

Start
2015-04
Primary completion
2026-07
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown 0.6 mg Subcutaneous
Subject Trimethaphan Small molecule 5 mg Intravenous

Indications